21 February 2025 in Rheumatology International
The aim of this study was to evaluate deep tendon reflex responses and associated electrophysiological parameters of the muscles in patients with fibromyalgia. This cross-sectional study included 38 patients with fibromyalgia and 32 age- and sex-matched controls. Deep tendon reflexes of the rectus femoris and triceps brachii were tested using a reflex hammer. Electromyographic (amplitude and duration of activation), inertial measurement unit (angular velocity, acceleration), and electromechanical (delay) analyses were performed using a surface electromyography (sEMG) device. Comparative analyses were carried out between patients and controls. Additionally, Receiver Operating Characteristic (ROC) analysis was performed to evaluate the ability of hyperreflexia in distinguishing fibromyalgia patients from controls. Hyperactive deep tendon reflexes in the right/left rectus femoris and/or triceps brachii were observed in more than 85% (ranging from 86.8 to 94.7%) of the fibromyalgia group. Patients with fibromyalgia exhibited significantly increased deep tendon reflex responses compared to controls (p < 0.001). Patients revealed significantly higher amplitude, longer duration of muscle activation, greater sagittal acceleration and angular velocity, and shorter electromechanical delay. Normalized muscle activation (right and left rectus femoris and right triceps brachii) in response to deep tendon reflex test showed acceptable ability in differentiating fibromyalgia patients from controls (Area under curve (AUC) = 0.890, 0.784 and 0.782, respectively). For the right rectus femoris, values ≤ 28.3 (clinically corresponding to normoactive/hypoactive deep tendon reflexes) appeared to rule-out fibromyalgia with 94.1% sensitivity and 61.3% specificity. Patients with fibromyalgia exhibit increased deep tendon reflex responses. Normal or decreased deep tendon reflex responses may probably be used as a rule-out criterion for fibromyalgia.
16 May 2025 in Rheumatology International
The study aimed to develop a quality of life (QoL) scale specific to patients with fibromyalgia. The scale development involved four steps: (1) Issue collection, (2) Face validity and selection of the most relevant items, (3) Formation of the preliminary scale and pilot testing, and (4) Psychometric evaluation. For psychometric evaluation, the scale was administered to a sample of fibromyalgia patients. Suitability for exploratory factor analysis (EFA) was assessed using the Kaiser–Meyer–Olkin (KMO) test and Bartlett's Test of Sphericity. Reliability was assessed with Cronbach's alpha, Guttman split-half test, and test–retest correlations. Construct validity was determined via EFA using Principal Axis Factoring. The correlation of the developed scale with established measures of QoL, fibromyalgia impact, fatigue, sleep, and mood was tested to assess convergent validity. Floor and ceiling effects were also examined. The initial item list included 25 issues related to QoL in fibromyalgia. Following the assessments and rating of the initial issue list through cognitive interviews, 10 issues were removed. The remaining questions were administered to 60 patients with fibromyalgia. The final version of the Fibromyalgia Quality of Life Scale (FM-QoLS) contained 14 items and two domains: symptomatology-functionality and psychosocial. Moderate-strong correlations between most items indicated that the scale has a homogeneous structure and measures the same construct. The FM-QoLS showed moderate-strong correlations with pain, anxiety, depression, sleep, fatigue, and established measures of QoL. Regarding the test–retest reliability of FM-QoLS items, the gamma values ranged from 0.923 to 0.995. The FM-QoLS is a 14-item QOL scale specific to patients with fibromyalgia. The scale has high validity and reliability, with no floor and ceiling effects. The FM-QoLS could help physicians address the multifaceted QoL challenges in fibromyalgia patients. Future research could refine the scale by exploring its use in different populations.
31 May 2023 in Marmara Medical Journal
Metabolic syndrome (MetS); is defined as a life-threatening endocrinopathy in which systemic disorders such as insulin resistance, abdominal obesity, glucose intolerance, diabetes mellitus, dyslipidemia, hypertension, and coronary artery disease are combined. Although, it is generally known as a problem of adults, it emerges as an essential problem in childhood and adolescence. MetS, closely related to obesity, is increasing due to bad eating habits and sedentary lifestyles. The pathophysiology of MetS has yet to be elucidated. Therefore, lifestyle changes, especially diet and physical activity, are the cornerstones of MetS treatment. In general, both physical activity and fitness; appear to be separately and independently associated with metabolic risk factors in children and adolescents. Although, studies show that activities that increase physical activity levels and improve aerobic fitness cause a decrease in the risk of MetS; a definitive prescription for exercise has not been established at this time. This review aimed to review the definition, classification, and factors playing a role in the pathogenesis of MetS, as well as to evaluate the relationship between MetS and physical activity and aerobic fitness in children.
6 November 2024 in Rheumatology International
2 April 2025 in Rheumatology International
Fibromyalgia is a complex condition characterized by widespread pain, fatigue, and various other symptoms. The symptoms of fibromyalgia overlap with numerous other disorders (e.g., infections, chronic fatigue syndrome), which makes diagnosis challenging. Existing diagnostic criteria for fibromyalgia rely particularly on subjective patient reports. Such a limitation may lead to both missed diagnoses and potential overdiagnoses. Recent research has identified significantly increased deep tendon reflex (DTR) responses in patients with fibromyalgia. The results also demonstrated the potential for DTR examination to help with the diagnostic process, particularly with ruling out fibromyalgia. The potential underlying mechanisms behind the increased DTR responses in fibromyalgia are central nervous system dysregulation, altered muscular properties, autonomic nervous system dysfunction, and accompanying conditions such as hypomagnesemia and anxiety. By integrating DTR responses into current diagnostic criteria sets, physicians may more effectively differentiate fibromyalgia from other conditions and avoid the pitfalls of misdiagnosis, as well as overdiagnosis. The use of DTR testing in the diagnostic evaluation of fibromyalgia shows promise. Yet, it has both advantages and limitations. The potential benefits of this approach include improved diagnostic accuracy, but challenges remain in its low specificity. This means that hyperreflexia testing alone is not definitive in diagnosing fibromyalgia. Nonetheless, given the high sensitivity, a decreased DTR response could still contribute to ruling out fibromyalgia.
5 December 2025 in Clinical Rheumatology